Live Breaking News & Updates on Neumora Therapeutics Daily|Page 7

Stay updated with breaking news from Neumora therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Buying: Neumora Therapeutics, Inc. (NASDAQ:NMRA) Director Acquires 17,275 Shares of Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) Director Kristina Burow purchased 17,275 shares of the firm’s stock in a transaction that occurred on Friday, November 10th. The shares were acquired at an average cost of $11.49 per share, with a total value of $198,489.75. Following the completion of the transaction, the director now owns […] ....

United States , William Blair , Kristina Burow , Jpmorgan Chase Co , Citigroup Inc , Royal Bank , Securities Exchange Commission , Neumora Therapeutics Inc , Neumora Therapeutics , Get Free Report , Director Kristina Burow , Exchange Commission , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,

Insider Buying: Neumora Therapeutics, Inc. (NASDAQ:NMRA) Major Shareholder Purchases 30,192 Shares of Stock

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 30,192 shares of the business’s stock in a transaction that occurred on Tuesday, November 7th. The stock was acquired at an average price of $11.50 per share, for a total transaction of $347,208.00. Following the acquisition, the insider now […] ....

United States , William Blair , Royal Bank , Jpmorgan Chase Co , Neumora Therapeutics Inc , Citigroup Inc , Arch Venture Partners Xii Llc , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Venture Partners Xii , Therapeutics Stock Down , Neumora Therapeutics Daily , Nasdaq Nmra , Insider Trading , Nsider Trades ,

Neumora Therapeutics (NASDAQ:NMRA) Price Target Cut to $20.00 by Analysts at JPMorgan Chase & Co.

Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by JPMorgan Chase & Co. from $21.00 to $20.00 in a report released on Wednesday morning, Benzinga reports. They currently have an overweight rating on the stock. Other research analysts have also recently issued reports about the stock. William Blair assumed coverage on shares […] ....

United States , William Blair , Stifel Nicolaus , Kristina Burow , Jpmorgan Chase Co , Neumora Therapeutics Inc , Neumora Therapeutics Company Profile , Royal Bank , Securities Exchange Commission , Arch Venture Partners Xii Llc , Neumora Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Arch Venture Partners Xii , Director Kristina Burow , Neumora Therapeutics Daily , Nasdaq Nmra , Lower Price Target , Jpmorgan Chase Co ,

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Consensus Target Price from Analysts

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Consensus Target Price from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Kristina Burow , William Blair , Stifel Nicolaus , Neumora Therapeutics Inc , Jpmorgan Chase Co , Arch Venture Partners Xii Llc , Neumora Therapeutics Company Profile , Royal Bank , Securities Exchange Commission , Neumora Therapeutics , Get Free Report , Arch Venture Partners Xii , Director Kristina Burow , Exchange Commission , Free Report , Get Free , Neumora Therapeutics Daily ,

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Down 5.8%

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) was down 5.8% on Monday . The stock traded as low as $10.71 and last traded at $10.99. Approximately 55,605 shares changed hands during trading, a decline of 86% from the average daily volume of 408,033 shares. The stock had previously closed at $11.67. Analysts Set New […] ....

United States , Kristina Burow , William Blair , Royal Bank , Amgen Inc , Securities Exchange Commission , Jpmorgan Chase Co , Neumora Therapeutics Company Profile , Exchange Commission , Neumora Therapeutics Inc , Neumora Therapeutics , Get Free Report , Therapeutics Trading Down , Director Kristina Burow , Free Report , Neumora Therapeutics Daily , Nasdaq Nmra ,